Sensus Healthcare, Inc. stock is up 3.15% since 30 days ago. The next earnings date is Feb 8, 2024. The company has had below-average volume in the last 30 days. Its seasonality going into this month shows a chance of a green month, as 50% of the previous 7 December’s closed higher than November. 100% of analysts rate it a buy.
Sensus Healthcare, Inc. manufactures and sells radiation therapy devices to healthcare providers worldwide. The company uses superficial radiation therapy (SRT), a low-energy X-ray technology in its portfolio of treatment devices. SRT-100 is an alternative to surgery for treating non-melanoma skin cancers, including basal cell and squamous cell skin cancers.